monovalent influenza vaccine (MF-59-adjuvanted) (Avidity NanoMedicines/Transgene/University of Siena/University of Turin)
N/A
Report date: 2025/01/26 17:12:00
Base Information
Drug Namemonovalent influenza vaccine (MF-59-adjuvanted) (Avidity NanoMedicines/Transgene/University of Siena/University of Turin)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvidity Biosciences Inc
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of TorinoTransgene SaUniversity Of Siena +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A